Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00999297 · ClinicalTrials.gov registry record · NA

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate

A NA study of Obesity and Weight, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
79
Enrollment target
1
Study location

NCT00999297: Completed NA study of Obesity and Weight, sponsored by Pennington Biomedical Research Center.

NCT00999297 is a NA study of Obesity and Weight that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 79 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00999297, a NA study of Obesity and Weight, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target
1
Study location

Study Summary

A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.

Conditions Studied

Interventions

  • OTHER Dihydrocapsiate

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2008-07
Est. Completion 2014-12
Phase NA

What the finished NCT00999297 record still lists

NCT00999297 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Dihydrocapsiate is the first listed.

NCT00999297 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT00999297 about?

NCT00999297 is a clinical study titled "Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate". A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.

What is the current status of trial NCT00999297?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2008-07. Estimated completion is 2014-12.

What conditions does trial NCT00999297 study?

This clinical trial studies the following conditions: Obesity, Weight.

What interventions are being tested in trial NCT00999297?

The interventions under investigation include: Dihydrocapsiate (OTHER).

Who is sponsoring clinical trial NCT00999297?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00999297 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00999297's enrollment target sits among peer trials

79 557th of 1053 higher than 494 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00999297, the US trial registry maintained by the National Library of Medicine. NCT00999297 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.